News about Manufacturing

Samsung Biologics Expands into US with GSK Facility Acquisition in Maryland

Samsung Biologics Expands into US with GSK Facility Acquisition in Maryland

Samsung Biologics has completed the acquisition of a biologics manufacturing facility in Rockville, Maryland from GSK, marking its first manufacturing presence in the United States.

Manufacturing | 02/04/2026 | By Darshana 140

Lilly to Acquire Centessa in USD 6.3 Billion Deal, Expands Neuroscience Pipeline

Lilly to Acquire Centessa in USD 6.3 Billion Deal, Expands Neuroscience Pipeline

Eli Lilly and Company has announced a definitive agreement to acquire Centessa Pharmaceuticals plc, strengthening its neuroscience portfolio and advancing next-generation therapies for sleep-related and neurological disorders.

Manufacturing | 01/04/2026 | By Darshana 127

Eveliqure and Serum Institute of India Partner to Develop Anti-Diarrhoeal Vaccines

Eveliqure and Serum Institute of India Partner to Develop Anti-Diarrhoeal Vaccines

Eveliqure and Serum Institute of India (SII) have partnered to develop anti-diarrhoeal vaccines, with Eveliqure set to receive an upfront payment, milestone-based earnings and royalties on net sales, while SII will lead development and global commercialisation.

Manufacturing | 23/03/2026 | By News Bureau 122

AstraZeneca to Build Cell Therapy Hub and Innovation Centre in Shanghai

AstraZeneca to Build Cell Therapy Hub and Innovation Centre in Shanghai

AstraZeneca has announced plans to set up a new cell therapy manufacturing and supply base along with an innovation centre in Shanghai, strengthening its presence in one of its key global markets.

Manufacturing | 20/03/2026 | By Darshana 157

LGM Pharma Expands US Manufacturing, Invests USD 15 Million in Texas and Colorado

LGM Pharma Expands US Manufacturing, Invests USD 15 Million in Texas and Colorado

LGM Pharma has expanded its US manufacturing with a total USD 15 million investment across Texas and Colorado, boosting CDMO capacity for suppository, semi-solid and oral solid dose production while strengthening domestic supply chains for finished dosage manufacturing.

Manufacturing | 20/03/2026 | By News Bureau 140

Lupin Manufacturing Solutions Scales Up Dabhasa Manufacturing Facility

Lupin Manufacturing Solutions Scales Up Dabhasa Manufacturing Facility

Lupin Manufacturing Solutions has expanded its Dabhasa facility with a new block and dedicated peptide manufacturing units, strengthening its CRDMO capabilities and boosting capacity for advanced pharma development and production.

Manufacturing | 19/03/2026 | By News Bureau 125

Dr Jitendra Singh Lays Foundation for INR 600 Crore Orchid Pharma Project in J&K

Dr Jitendra Singh Lays Foundation for INR 600 Crore Orchid Pharma Project in J&K

Dr Jitendra Singh laid the foundation for an INR 600 crore multinational pharma manufacturing facility in Kathua, highlighting the region’s rising industrial potential and its role in strengthening India’s pharma exports and economic growth.

Manufacturing | 18/03/2026 | By Akanki 142

Eli Lilly Commits USD 3 Billion To Expand China Manufacturing

Eli Lilly Commits USD 3 Billion To Expand China Manufacturing

Eli Lilly and Company plans to invest USD 3 billion in China over the next decade to expand its local manufacturing and supply chain capabilities as it prepares for potential demand for new diabetes and obesity treatments.

Manufacturing | 12/03/2026 | By Darshana 134

VolitionRx Completes Automation Validation For Nu.Q Vet Cancer Test In Japan

VolitionRx Completes Automation Validation For Nu.Q Vet Cancer Test In Japan

VolitionRx Limited has completed validation and verification of the chemiluminescent immunoassay (ChLIA) version of its Nu.Q Vet Cancer Test in collaboration with Fujifilm Vet Systems Co. Ltd in Japan, enabling the test to be run through fully automated systems in central laboratories instead of manual plates.

Manufacturing | 09/03/2026 | By Darshana 143

U.S. Food and Drug Administration Grants De Novo Classification to LifeVac as Second-Line Emergency Treatment

U.S. Food and Drug Administration Grants De Novo Classification to LifeVac as Second-Line Emergency Treatment

U.S. Food and Drug Administration grants De Novo clearance to LifeVac, classifying it as a Class II medical device for use as a second-line treatment in choking emergencies.

Manufacturing | 09/03/2026 | By News Bureau 352

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members